Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Beovu® (Brolucizumab) for the Treatment of wet Age-related Macular Degeneration (AMD)

BEOVU is the first FDA-approved anti-VEGFA drug available for wet AMD. Credit: Novartis.



  • Beovu®
  • BEOVU
  • BEOVU
  • BEOVU
Close
Close
Close

Go Top